MS and Flukes: Why This Parasite Appears in Almost Every Chronic Disease

There is a parasite living inside millions of people right now.

Experts call it a neglected parasitic infection. The World Health Organization classifies it as an emerging global public health concern. It is found on every continent except Antarctica — including North America, Europe, and the Americas.

It causes severe, sustained inflammation. It is directly linked to cancer and neurological disease. It can live inside the human body for decades.

And almost no doctor in the developed world is testing for it.

This parasite is called a fluke. And it may be one of the most significant and most overlooked root causes of chronic disease today.

What Is a Fluke?

Flukes are parasitic flatworms — scientifically called trematodes. They are not roundworms. They are not tapeworms. They belong to an entirely separate category and behave very differently from any parasite most people have heard of.

Key facts:

• Approximately 70 fluke species are known to inhabit the human digestive tract alone
• An estimated 40 to 50 million people worldwide are infected with intestinal flukes
• Hundreds of millions more are considered at risk
• Flukes are documented in over 70 countries on every continent except Antarctica
• The WHO classifies liver fluke infection as an emerging and neglected public health concern

Each species prefers to live in one specific part of the body. Where the fluke lives determines which organs are damaged and which symptoms develop.

 

Where Flukes Live in the Body

Liver and Bile Ducts

• Species: Fasciola hepatica, Clonorchis sinensis, Opisthorchis viverrini
• Fasciola is primarily a cattle and sheep parasite that regularly infects humans
• Clonorchis and Opisthorchis are fish-borne liver flukes
• All three migrate to the liver and live in the bile ducts, gallbladder, and smaller internal ducts
• Linked to bile duct cancer — one species is classified as a Group 1 carcinogen by the IARC, the same category as tobacco

Intestines

• Species: Fasciolopsis buski, Heterophyes heterophyes
• Attach directly to the intestinal lining and feed on host cells and digested food
• Cause bleeding, ulceration, and severe malabsorption in heavier infections

Blood Vessels

• Species: Schistosoma (blood flukes)
• They live inside blood vessels
• Eggs travel through the bloodstream and lodge in the liver, bowel wall, bladder, spinal cord, and brain
• The eggs cause significant damage also
• Believed by integrative practitioners to be the greatest parasitic cause of bladder dysfunction — extremely common in MS and other chronic conditions

Lungs

• Species: Paragonimus (lung flukes)
• Travel through the abdominal wall and diaphragm, into the lung tissue
• Form cysts inside the lungs
• Routinely misdiagnosed as tuberculosis. Shows as a chronic cough with blood-streaked sputum, chest pain, pneumonia that does not respond to antibiotics
• Some patients have been on months of TB treatment before the correct diagnosis was made

Ectopic Sites

• Flukes can travel outside their preferred location
• Documented in published case reports: brain, spinal cord, skin, eyes
• When flukes reach the central nervous system: seizures, weakness, paralysis, cognitive changes
• These are not theoretical. They are documented in the peer-reviewed medical literature

 

How Common Are Flukes?

Standard teaching says fluke infections stay in tropical endemic regions. The data tells a different story.

Global infection numbers:

• Fasciola hepatica: WHO estimates 2.6 to 17 million infected worldwide
• Clonorchis and Opisthorchis (fish-borne liver flukes): tens of millions infected
• Schistosoma: over 240 million people affected yearly across 78 countries — the second most serious parasitic infection in humans after malaria
• Intestinal flukes: estimated 40 to 50 million infected worldwide

The livestock connection nobody talks about:

• Studies in Latin America found trematode infections in 30 to 40% of cattle
• Fasciola hepatica alone found in 18 to 20% of animals
• Cattle share water with agricultural land
• Their waste contaminates irrigation water and soil
• Vegetables grown in those conditions can carry encysted parasites

The diagnostic gap:

• Standard testing looks for eggs in stool samples
• In light infections: cases are routinely missed
• In extra-intestinal infections: eggs may never appear in stool at all
• Serological blood tests exist but are not routinely ordered in North America or Western Europe
• Doctors do not test, cases are not found, prevalence appears low

The official numbers are almost certainly the floor, not the ceiling.

 

The Accepted Lifecycle — And Three Questions Science Has Never Answered

Every textbook describes the fluke lifecycle with great confidence:

1. Adult flukes in the host lay eggs
2. Eggs leave the body in feces or sputum
3. Eggs reach freshwater and hatch into free-swimming larvae (miracidia)
4. Larvae infect a specific freshwater snail
5. The parasite develops inside the snail over weeks to months
6. It emerges and either encysts on aquatic vegetation, penetrates into fish or crabs, or penetrates human skin directly (blood flukes)
7. Humans are infected by eating contaminated fish or plants, or through skin contact with infested water.

Based on this model, medicine makes two confident claims:

• Flukes cannot spread from person to person
• A fluke cannot reinfect the same host it is already living in.

What the textbooks do not say is that these claims have never been directly tested. They have never been proven!

Question 1: Can fluke eggs hatch inside the human body?

The standard answer is no. But:

• No human or animal study has ever been designed to prove this
• No controlled experiment has tested whether hatching could occur in human tissue, the gut environment, or any internal niche
• The claim rests on ecological observation — not on direct negative evidence from human or animal studies.

Question 2: Can a fluke infection self-perpetuate inside a person who is already infected?

The official answer is no — because the snail stage is required. But:

• No study has followed infected humans long-term and ruled out every possible internal mechanism
• These parasites may live for decades, produce tens or hundreds of thousands of eggs per day, and actively suppress host immunity
• They have every evolutionary incentive to find ways to persist in the host
• Whether they have done so in ways not yet documented is an open question, not a settled one.

Question 3: Can flukes spread directly from one person to another?

The official position: impossible without a snail. But:

• No study has tested whether fluke eggs can survive on shared household surfaces
• No study has examined whether any stage of the parasite could pass between people through close contact
• That claim has never been tested. It has simply been assumed.

What is seen in the Live Disease Free community:

• Family members develop the same symptoms and pass the same parasitic material — but at different times
• If a shared meal or water source were the only cause, everyone would get sick at the same time
• When one person gets sick first and others follow weeks or months later, that points to the possibility that infection is spreading from one person to the next inside the household
• People can also relapse within weeks of stopping treatment with no new identifiable external exposure.

None of these patterns are explained by the standard lifecycle diagram. None of them have been investigated by researchers specifically designing studies to test those possibilities.

 

How Long Flukes Live and How Many Eggs They Produce

Estimated lifespans inside the human body:

• Fasciola hepatica: 5 to 13 years in the bile ducts
• Clonorchis sinensis and Opisthorchis: 20 to 30 years
• Schistosoma (blood flukes): 5 to 10 years or more

Important note: these figures come from clinical observations of long-term egg shedding and animal data — not from controlled experiments tracking individual worms from infection to death. The true maximum lifespan is incompletely defined.

Daily egg output:

• Adult Fasciola: estimated thousands of eggs per worm per day
• One adult worm over 10 years releases millions of eggs
• Multiple worms over multiple decades means an almost incomprehensible volume of biological material continuously deposited in and around tissues
• Every egg triggers an inflammatory response

That biological scale means there are an enormous number of opportunities for non-classical persistence or transmission to occur, even at very low efficiency.

 

Symptoms: The Complete Picture

Flukes cause significant inflammation throughout the body. That is why the symptom list is broad, multi-system, and largely non-specific. And exactly why it gets attributed to something else.

Liver and Biliary Flukes: Acute Infection

• Right upper abdominal pain and tenderness
• Fever, chills, night sweats
• Nausea, vomiting, loss of appetite
• Significant fatigue and weight loss
• Urticarial skin rash and generalized itching
• Enlarged liver detectable on imaging
• Blood tests: eosinophilia, elevated liver enzymes

Liver and Biliary Flukes: Chronic Infection

• Cramping pain in the right upper abdomen
• Chronic bloating and dyspepsia
• Greasy stools and fat malabsorption
• Intermittent jaundice with dark urine and pale stools
• Chronic bile duct inflammation leading to strictures, gallstones, and obstruction
• Recurrent bacterial infections in the biliary tree
• Progressive liver fibrosis, in some settings cirrhosis
• Anemia
• In children: measurably impaired cognitive development and growth

Cancer Risk

• Clonorchis sinensis and Opisthorchis viverrini are recognized direct causes of bile duct cancer
• The IARC classifies Opisthorchis viverrini as a Group 1 carcinogen in the same classification as tobacco
• This is mainstream oncology, not alternative medicine
• Cancer risk persists even after apparent resolution of active infection

Ectopic Manifestations

• Mass-like lesions in subcutaneous tissues, lungs, or brain which are often mistaken for tumors
• Seizures and neurological symptoms like numbness, weakness, or vision changes when flukes reach the brain

 

Intestinal Flukes

What they feed on: the cells and cell fragments of the host and digested food in the small intestine

Early symptoms:

• Often none or minimal
• Hunger pangs which is an early and easily missed sign
• Abdominal pain and altered bowel habits typically appear 1 to 2 months after infection

As worm burden increases:

• Abdominal cramping that worsens after eating
• Chronic diarrhea or alternating diarrhea and constipation
• Bloody diarrhea in some cases
• Persistently foul-smelling greenish-yellow diarrhea
• Bloating, gas, nausea, vomiting, early satiety
• Weight loss, malaise, fever

Tissue and structural damage:

• Ulceration and mucus secretion at attachment sites
• Allergic reactions including facial swelling and leg swelling
• Fluid buildup in the abdominal cavity

Nutritional deficiencies caused by fluke infection:

• Protein loss through the gut leading to low protein levels in the blood, swelling in the legs and feet
• Vitamin B12 deficiency leading to anemia and nerve damage
• Low calcium, magnesium, and potassium leading to muscle cramps, spasms, and stiffness
• Vitamin B1 (Thiamine) deficiency leading to nerve damage and muscle stiffness

Neurological and systemic effects:

• Headaches, dizziness, vertigo
• Cognitive impairment, irritability, depression, anxiety
• Peripheral neuropathy – tingling and burning sensations
• Seizures

Serious complications in heavy infections:

• Myocarditis and heart failure from some larval species
• Brain bleeds from some species
• Spinal cord lesions affecting motor and sensory function
• Intestinal obstruction or perforation
• Severe infections can be fatal
• Immune suppression increasing susceptibility to Giardia, Entamoeba histolytica, sepsis

Schistosoma Blood Flukes  

Acute phase:

• Fever, chills, cough, muscle aches
• Skin hives, high levels of immune cells in the blood, and overwhelming exhaustion

Chronic intestinal schistosomiasis:

• Abdominal pain, diarrhea, blood in stool
• Portal hypertension, progressive spleen enlargement
• Esophageal varices that can rupture and bleed catastrophically

Urinary schistosomiasis:

• Blood in urine, urgency, frequency
• Bladder wall thickening, swelling of the kidneys due to urine backup
• Significantly increased risk of bladder cancer

Female genital schistosomiasis:

• One of the most under-diagnosed conditions in global health
• Genital ulcers, abnormal bleeding, infertility

Neurologic schistosomiasis:

• Eggs reach spinal cord or brain
• Weakness, paralysis, seizures

Lung Flukes: Paragonimus

• Chronic cough with blood-streaked sputum
• Chest pain, shortness of breath, wheezing
• Recurrent pneumonia that does not respond to antibiotics
• Pleural effusions
• One of the most commonly TB-misdiagnosed parasitic infections in the world
• When flukes reach the brain: seizures, severe headaches, permanent neurological deficits

Systemic Picture Across All Fluke Types

• Eosinophilia on blood tests
• Chronic low-grade or intermittent fever
• Profound and often disabling fatigue
• Urticarial and skin reactions
• Anemia
• Cognitive changes and mood disturbances
• Multi-system dysfunction that looks like immune dysregulation of unknown origin

In the Live Disease Free community: the most common presentation is someone told for years they have MS, fibromyalgia, an autoimmune condition, or chronic fatigue syndrome, who is exhausted, inflamed, and multi-system unwell in exactly the pattern that chronic fluke infection produces.

The overlap is striking. It is documented in the literature. It deserves investigation rather than dismissal.

 

Flukes at the Center of Stones

Most people have been taught that gallstones are a cholesterol and bile chemistry problem. For many stones, published research tells a very different story.

The 2022 systematic study:

• 33 gallbladder stones analyzed using light microscopy, scanning electron microscopy, and elemental mapping
• Clonorchis sinensis eggs found inside 30 of the 33 stones
• In every calcium carbonate and every mixed stone: the core contained fluke eggs and fluke tissue wrapped in calcium salts
• Conclusion: the fluke entered the gallbladder first. The stone grew around it.

Earlier supporting studies:

• 2004, World Journal of Gastroenterology: Opisthorchis viverrini eggs found with calcium bilirubinate deposited directly on the eggshell surface. The egg was the seed for stone formation.
• 2011, Korean Journal of Radiology: Clonorchis eggs found wrapped in bilirubinate granules and calcium crystals inside gallbladder stones. The egg was the initiating structure.

In the urinary tract:

• Schistosoma eggs lodge in the bladder wall
• Trigger inflammation, calcification, and stone formation
• Eggs have been found embedded in calcified tissue surrounding bladder stones

When students pass stone-like material packed with biological content during intensive protocols, this published research explains exactly why.

 

Standard Treatments

Mainstream medicine has pharmaceutical options for fluke infections — when the infection is correctly identified.

Triclabendazole

Herxheimer-Like Reactions

• Treatment can trigger sudden inflammatory reactions from toxins released by dying flukes
• Severe cases: respiratory failure, brain inflammation, cognitive dysfunction
• Patients with CNS parasitic involvement must be monitored closely
• Healthcare provider may prescribe steroids to prevent a life-threatening CNS reaction
• This is why preparing the body before treatment is essential

Additional Agents With Supporting Evidence

• Niclosamide 
• Artesunate 
• Thiabendazole, mebendazole, levamisole, pyrantel pamoate
• Albendazole
• Artemisinin 
• Combination protocols are more effective than single-drug approaches for persistent infections

Why Diagnosis Is So Often Missed

• Standard stool tests are frequently inaccurate — false negatives are common
• A negative stool test does not rule out a fluke infection

Additional methods: PCR testing, merthiolate-iodine-formalin concentration

Energy testing by skilled integrative practitioners can help identify appropriate treatments

How Cure Is Defined 

In published treatment studies, cure = egg negativity in a stool test at follow-up. That is not the same as:

• Confirming every adult worm has been killed
• Verifying every life stage in protected niches has been reached
• Reversing organ damage, fibrosis, and chronic inflammation

Egg negativity after treatment does not equal full biological eradication.

For people with complex chronic illness:

• Many infections were never detected. Testing is not sensitive enough
• Multiple species may be present, each requiring a different drug
• Long-standing tissue damage cannot be reversed by a drug alone
• Co-infections, nutritional deficiencies, and immune dysfunction must all be addressed

 

What Is Seen in the Live Disease Free Community

Pam Bartha and the Live Disease Free team did not fully appreciate how common flukes were until students began submitting parasite images that were very characteristic of fluke infection especially while they were taking medications that treat flukes. These same students tested well for fluke-specific drugs.

As these parasites are passed, inflammation decreases dramatically and quickly.

 

Why Flukes Are So Difficult to Eradicate

1. Extraordinary Lifespan

• Fasciola: estimated 5 to 13 years
• Clonorchis and Opisthorchis: estimated 20 to 30 years
• Schistosoma: 5 to 10 years or more
• A parasite that entered the body decades ago may still be active today

2. Massive Egg Volume

• One adult Fasciola over 10 years produces hundreds of millions of eggs
• Each egg triggers inflammation
• Structural damage accumulates over decades and does not disappear when the worm dies

3. Active Immune Manipulation

• Flukes do not just evade immunity,  they actively redirect it
• They push the immune response toward allergy and chronic inflammation
• Away from the response that would most effectively eliminate them
• This is why chronic fluke patients so often also have multiple food sensitivities, unexplained inflammatory conditions, and immune dysregulation

4. Permanent Tissue Damage

• Fibrosis in the liver and bile ducts
• Strictures and gallstones
• Intestinal scarring, bladder wall thickening
• Bile duct cancer risk persists even after active infection appears resolved
• Damage requires targeted long-term support to recover — it does not reverse passively

5. Zoonotic Reservoirs

• Livestock and wildlife continuously reseed the environment with fluke eggs
• Exposure continues through water, soil, and food systems connected to animal agriculture
• This is a systems-level problem that individual behavior cannot fully control

6. Diagnostic Blind Spots

• Most infected people in industrialized countries are never correctly diagnosed
• By the time people reach a program like Live Disease Free, many have been sick for a decade or longer
• The condition has been continuously misattributed to something else

7. Co-infections and Biofilms

• Flukes rarely travel alone
• They coexist with other worms, Borrelia, Candida, viral infections
• Biofilms dramatically reduce drug penetration to protected parasite populations
• Treating one organism at a time without addressing the broader microbial picture is why short-course treatments fail

8. The Unresolved Questions

• Standard treatment assumes a single source of infection. But if reinfection is happening through household contact or daily life, a more thorough and ongoing approach is needed and the research to confirm this has not yet been done.

 

Recovery: What Is Possible

Meaningful recovery from chronic parasitic infection is possible. Over 2,000 students across more than 15 countries have demonstrated this through the Live Disease Free program.

Recovery is not a one-drug, one-month event. It requires a sustained, layered approach:

Diet — the non-negotiable foundation

• Flukes thrive in an inflamed, high-sugar, nutrient-depleted body
• Changing the internal environment is not optional — it is the foundation everything else builds on

Immune support

• A body suppressed for decades cannot spontaneously recover immune function
• Preparing to treat is a necessary step

Co-infections and biofilm disruption

• The microbial picture is almost always layered
• Antiparasitic work must integrate bacterial, protozoal and fungal infection management
• Biofilm disruption is often necessary before drugs can reach protected parasites

Supported antiparasitic treatment

• Pharmaceutical, herbal, or a combination must always be supervised with a qualified practitioner
• Dying parasites release a significant inflammatory and toxic burden
• Liver, lymphatic system, and kidneys need active support to process that load
• Without preparation, die-off reactions can be severe enough to stop treatment prematurely

Time and realistic expectations

• Recovery is measured in months, sometimes longer
• Waves of symptom shifts and die-off reactions are real — they are not failure
• Understanding what is happening biologically during recovery is one of the most important things anyone on this journey can have.

 

If you have been sick for a long time and told that there is no identifiable cause — you are not imagining your symptoms.

The research covered in this article comes from the WHO, the International Agency for Research on Cancer, and peer-reviewed journals. It supports the position that parasitic infections are far more common, far more consequential, and far more under-diagnosed than the medical mainstream currently acknowledges.

The body is designed to recover when the conditions for recovery are in place: remove what should not be there, restore what has been depleted, and support the systems that have been carrying an enormous burden.

 

There are real solutions to recover from parasites today!

To restore health, we must focus on treating the cause of inflammation, which are parasites. First, identify the enemy (parasites), then support the body and treat the parasites while following a holistic approach. When parasitic infections are treated effectively, we can overcome inflammation or disease.

If you’re frustrated with the fact that our standard of care STILL doesn’t offer a real solution for treating MS and other diseases, then click on the link below to watch Pam Bartha’s free masterclass training and discover REAL solutions that have allowed Pam and many others to live free from MS and other diseases.

CLICK Here to watch Pam’s masterclass training

 

References

1. World Health Organization. Foodborne trematode infections. Geneva, Switzerland: World Health Organization; 2021.
   Key finding: WHO identifies foodborne trematode infections (including liver, intestinal, and lung flukes) as neglected tropical diseases that affect tens of millions of people and require integrated control.
   URL: https://www.who.int/news-room/fact-sheets/detail/foodborne-trematode-infections
2. Fürst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(3):210-221.
   Key finding: Systematic review estimating tens of millions of human infections with foodborne trematodes and highlighting major surveillance and reporting gaps, especially in high‑income countries.
   URL: https://pubmed.ncbi.nlm.nih.gov/22108757/
3. Keiser J, Utzinger J. Food-borne trematodiases. Clin Microbiol Rev. 2009;22(3):466-483.
   Key finding: Comprehensive review of epidemiology, lifecycle biology, clinical manifestations, diagnostics, and treatment for key foodborne trematodes including Fasciola, Clonorchis, Opisthorchis, and Paragonimus.
   URL: https://pubmed.ncbi.nlm.nih.gov/19597009/
4. Mas-Coma S, Bargues MD, Valero MA. General overview of the current status of human foodborne trematodiasis. Acta Trop. 2022;231:106438.
   Key finding: Updated global overview of human foodborne trematodiases, emphasizing under‑estimation of prevalence, incomplete mapping, and continued neglect in non‑endemic as well as endemic regions.
   URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10090779/
5. Torgerson PR, Devleesschauwer B, Praet N, et al. World Health Organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010. PLoS Med. 2015;12(12):e1001920.
   Key finding: WHO‑commissioned analysis estimating about 2 million DALYs from foodborne trematodiases and confirming them as major contributors to global disability and premature death.
   URL: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001920
6. Kassebaum NJ, et al. Global prevalence of four neglected foodborne trematodes targeted for control by WHO: a scoping review to highlight the gaps. PLoS Negl Trop Dis. 2023;17(3):e0011073.
   Key finding: Quantifies global prevalence for clonorchiasis, opisthorchiasis, fascioliasis, and paragonimiasis, and identifies major data gaps that threaten achievement of WHO 2030 NTD targets.
   URL: https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0011073&type=printable
7. Tambo E, Madjou G, Zhou XN, Khater EI. Global, regional and national disease burden of food-borne trematodiases: projections to 2030 based on the Global Burden of Disease Study 2021. Int J Parasitol. 2024;54(12):xxx-xxx.
   Key finding: Uses GBD 2021 data to project that mortality and DALYs from foodborne trematodiases will remain substantial through 2030, with highest burdens in Southeast Asia and Western Pacific regions.
   URL: https://pubmed.ncbi.nlm.nih.gov/39676162/
8. World Health Organization. Promoting prevention and control of foodborne trematode infections using a One Health approach. Geneva, Switzerland: World Health Organization; 2024.
   Key finding: WHO implementation brief calling for integrated One Health strategies (veterinary, environmental, food safety, and human chemotherapy) to control foodborne trematode infections.
   URL: https://www.who.int/activities/promoting-prevention-and-control-of-foodborne-trematode-infections-using-a-one-health-approach
9. Mas-Coma S, Valero MA, Bargues MD. Food-borne trematode infections. In: WHO Study Group on the Control of Foodborne Trematode Infections. WHO Technical Report Series 849. Geneva, Switzerland: World Health Organization; 1995.
   Key finding: Early WHO technical report estimating ~40 million human infections and explicitly linking liver flukes with cholangiocarcinoma, gallstones, and severe hepatobiliary disease.
   URL: https://iomc.info/publications/i/item/WHO-TRS-849
10. World Health Organization. Schistosomiasis. Geneva, Switzerland: World Health Organization; 2023.
    Key finding: WHO fact sheet documenting schistosomiasis as affecting >240 million people in 78 countries annually, with ~290 million needing preventive treatment in 2018.
    URL: https://www.who.int/news-room/fact-sheets/detail/schistosomiasis
11. Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368(9541):1106-1118.
    Key finding: Comprehensive clinical review of schistosomiasis covering acute and chronic disease, neuroschistosomiasis, female genital schistosomiasis, and treatment.
    URL: https://pubmed.ncbi.nlm.nih.gov/16997665/
12. Hotez PJ, Brindley PJ, Bethony JM, et al. Helminth infections: the great neglected tropical diseases. J Clin Invest. 2008;118(4):1311-1321.
    Key finding: Landmark review establishing helminths, including trematodes, as major neglected tropical diseases and describing their links to poverty, malnutrition, and chronic illness.
    URL: https://pubmed.ncbi.nlm.nih.gov/18382743/
13. Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis. 2007;1(2):e114.
    Key finding: Introduces DALY‑based burden estimates for NTDs, showing that trematode infections impose far more disability than case counts alone reveal.
    URL: https://pubmed.ncbi.nlm.nih.gov/18060077/
14. Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367(9521):1521-1532.
    Key finding: Defines key principles of chronic helminth infection, immune modulation, and nutritional consequences that also apply to trematodes and mixed helminth infections.
    URL: https://pubmed.ncbi.nlm.nih.gov/16679166/
15. Marcos LA, Terashima A, Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis. 2008;21(5):523-530.
    Key finding: Clinical update on major hepatobiliary flukes, detailing acute and chronic manifestations, ectopic disease, diagnostics, and treatment, and emphasizing oncologic consequences.
    URL: https://pubmed.ncbi.nlm.nih.gov/18725803/
16. Choi D, Lim JH, Lee KT, et al. Liver flukes: the malady neglected. Korean J Radiol. 2011;12(3):269-279.
    Key finding: Radiologic and clinical review documenting C. sinensis eggs within stones and bile; SEM images show eggs wrapped in pigment and calcium, suggesting eggs as a central factor in stone formation and biliary disease.
    URL: https://pubmed.ncbi.nlm.nih.gov/21603286/
17. SciDev/ScienceDirect Topics. Fasciola hepatica. Accessed April 26, 2026.
    Key finding: Overview of Fasciola hepatica biology, lifecycle, and distribution, with livestock prevalence data illustrating the scale of zoonotic reservoirs and ongoing human exposure risk.
    URL: https://www.sciencedirect.com/topics/veterinary-science-and-veterinary-medicine/fasciola-hepatica
18. Fairweather I. Liver fluke lifespans: reassessing the evidence. Vet Parasitol. 2024;319:109927.
    Key finding: Reviews evidence for published liver fluke lifespan estimates and concludes that human lifespan figures are extrapolated from clinical and animal data; the true maximum adult lifespan in humans remains uncertain.
    URL: https://pubmed.ncbi.nlm.nih.gov/39132065/
19. Qiao T, Li X, Zhang J, et al. A systematic study on 33 gallbladder stones resembling adult Clonorchis sinensis. J Helminthol. 2022;96:e84.
    Key finding: Systematic analysis of 33 gallbladder stones using microscopy and element mapping found C. sinensis eggs in 30 stones and fluke tissue wrapped in calcium at the core of all calcium‑carbonate and mixed stones, supporting flukes as the nidus.
    URL: https://pubmed.ncbi.nlm.nih.gov/36573372/
20. Sripa B, Kaewkes S, Sithithaworn P, et al. Opisthorchiasis-associated biliary stones: light and scanning electron microscopic study. World J Gastroenterol. 2004;10(20):3112-3116.
    Key finding: Shows Opisthorchis eggs embedded within biliary stones with calcium bilirubinate crystal deposition directly on eggshell surfaces, concluding that fluke eggs function as the nucleus for pigment stone formation.
    URL: https://pubmed.ncbi.nlm.nih.gov/15484308/
21. Sripa B, Bethony JM, Sithithaworn P, et al. Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop. 2011;120(Suppl 1):S158-S168.
    Key finding: Epidemiologic data from Thailand and Laos linking high O. viverrini prevalence to very high cholangiocarcinoma incidence; even low‑intensity infections carry significant cancer risk.
    URL: https://pubmed.ncbi.nlm.nih.gov/20655862/
22. Sripa B, Kaewkes S, Sithithaworn P, et al. Liver fluke–associated biliary tract cancer. Gut Liver. 2017;11(6):771-780.
    Key finding: Summarizes clinical, radiologic, and pathological features of liver fluke‑associated cholangiocarcinoma and details how chronic fluke infection remodels bile ducts into a carcinogenic field.
    URL: https://www.gutnliver.org/journal/view.html?doi=10.5009/gnl17102
23. Andrews RH, Sithithaworn P, Petney TN. Opisthorchis viverrini: an underestimated parasite in world health. Trends Parasitol. 2008;24(11):497-501.
    Key finding: Argues that O. viverrini infection is widely underestimated in global health metrics and that true prevalence likely far exceeds reported figures.
    URL: https://pubmed.ncbi.nlm.nih.gov/18930439/
24. Kim TS, Pak JH. Clonorchis sinensis and cholangiocarcinoma. Cancers (Basel). 2025;17(4):1132.
    Key finding: Up‑to‑date review of C. sinensis as a human carcinogen, summarizing epidemiologic risk estimates and molecular mechanisms by which chronic infection leads to cholangiocarcinoma.
    URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12040606/
25. Pak JH, Kim DW, Moon JH, et al. Natural history of liver fluke infection underpins epidemiological patterns of cholangiocarcinoma. Proc Natl Acad Sci U S A. 2025;122(5):e2423536122.
    Key finding: Modeling and longitudinal data indicate that around 5% of people with chronic liver fluke infection develop cholangiocarcinoma, with risk strongly related to infection intensity and duration.
    URL: https://www.pnas.org/doi/10.1073/pnas.2423536122
26. International Agency for Research on Cancer (IARC). Biological Agents. Volume 100B. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: IARC; 2012.
    Key finding: Classifies Opisthorchis viverrini as Group 1 carcinogen and Clonorchis sinensis as Group 2A (probable carcinogen) for bile‑duct cancer; S. haematobium is classified as Group 1 for bladder cancer.
    URL: https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Biological-Agents-2012
27. Allen JE, Maizels RM. Diversity and dialogue in immunity to helminths. Nat Rev Immunol. 2011;11(6):375-388.
    Key finding: Reviews how helminths induce Th2 and regulatory T‑cell responses, dampen Th1 immunity, and create broad immunomodulation that influences susceptibility to other infections and vaccines.
    URL: https://pubmed.ncbi.nlm.nih.gov/21610741/
28. Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol. 2002;2(7):499-511.
    Key finding: Describes how schistosomes drive Th2‑dominant and regulatory immune responses that permit long‑term survival in blood vessels while generating chronic granulomatous pathology.
    URL: https://pubmed.ncbi.nlm.nih.gov/12094224/
29. Carod-Artal FJ. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg. 2008;102(2):107-116.
    Key finding: Systematic review of neuroschistosomiasis documenting spinal cord and cerebral syndromes that can mimic demyelinating disease, including in non‑endemic countries.
    URL: https://pubmed.ncbi.nlm.nih.gov/17905371/
30. Torgerson PR, de Silva NR, Fèvre EM, et al. General overview of the current status of human foodborne trematodiasis. Acta Trop. 2022;231:106438.
    Key finding: Broad review of human foodborne trematodes outlining current prevalence estimates, clinical impact, and major research and surveillance gaps.
    URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10090779/
31. Van Dijk J, et al. Prospects and challenges towards sustainable liver fluke control. Parasitology. 2017;144(10):1296-1310.
    Key finding: Explores liver fluke control in livestock and humans, highlighting drug resistance, climate impacts on transmission, and the need for integrated strategies rather than reliance on single drugs.
    URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5656390/
32. UpToDate. Intestinal flukes. Waltham, MA: UpToDate, Inc. Accessed April 26, 2026.
    Key finding: Clinical reference summarizing epidemiology, clinical features, diagnostics, and treatment for major intestinal flukes; estimates 40–50 million people infected worldwide.
    URL: https://www.uptodate.com/contents/intestinal-flukes
33. Centers for Disease Control and Prevention. Fasciolopsiasis: biology. Atlanta, GA: CDC; Accessed April 26, 2026.
    Key finding: CDC overview of Fasciolopsis buski lifecycle, hosts, distribution, and clinical features; confirms infection via contaminated aquatic plants and poorly prepared foods.
    URL: https://www.cdc.gov/fasciolopsis/about/index.html